ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,724Medicare Part D Prescriptions Filled, Including Refills

Rank: 104 out of 1499

$888K Total Retail Price of All Prescriptions

Rank: 94 out of 1499

550 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 550 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 550 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 10,671 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
HYDROCODONE-ACETAMINOPHEN 864 467 S3 1 4
AMLODIPINE BESYLATE 423 341 2 6
SIMVASTATIN 386 295 3 3
LEVOTHYROXINE SODIUM 369 283 4 2
LISINOPRIL 362 267 5 1
OMEPRAZOLE 309 234 6 5
FUROSEMIDE 306 224 7 7
METFORMIN HCL 274 198 8 8
ZOLPIDEM TARTRATE 274 173 8 23
METOPROLOL TARTRATE 248 220 10 10
HYDROCHLOROTHIAZIDE 236 192 11 9
LOVASTATIN 222 193 12 19
CITALOPRAM HBR 219 132 13 14
TRAMADOL HCL 197 129 14 16
GABAPENTIN 191 107 15 13
TRAZODONE HCL 191 96 15 32
METOPROLOL SUCCINATE 175 147 17 20
DOXAZOSIN MESYLATE 168 146 18 104
LISINOPRIL-HYDROCHLOROTHIAZIDE 165 127 19 25
OXYCODONE HCL 157 15 S2 20 79
POTASSIUM CHLORIDE 153 114 21 11
PRAVASTATIN SODIUM 151 105 22 18
FLUOXETINE HCL 150 91 23 43
OXYCONTIN 145 32 S2 24 99
ATORVASTATIN CALCIUM 134 118 25 17
CYMBALTA 132 37 26 40
SPIRIVA 131 102 27 44
ROPINIROLE HCL 127 104 28 55
MIRTAZAPINE 126 101 29 50
CYCLOBENZAPRINE HCL 123 70 R 30 41
LOSARTAN POTASSIUM 122 114 31 26
TAMSULOSIN HCL 121 95 32 29
GLIMEPIRIDE 120 106 33 38
ALLOPURINOL 119 93 34 36
MELOXICAM 118 68 35 27
ATENOLOL 116 72 36 21
CELEBREX 113 28 37 77
NAPROXEN 112 78 38 63
CLOPIDOGREL 111 81 39 39
WARFARIN SODIUM 110 80 40 12
FLUTICASONE PROPIONATE 108 61 41 31
SERTRALINE HCL 107 25 42 24
AMITRIPTYLINE HCL 106 69 R 43 49
RANITIDINE HCL 104 56 44 15
ALENDRONATE SODIUM 101 101 45 33
RAMIPRIL 97 62 46 127
CARVEDILOL 97 61 46 22
HYDROMORPHONE HCL 96 67 S2 48 189
OXYCODONE HCL-ACETAMINOPHEN 91 29 S2 49 81
PROAIR HFA 87 47 50 30
SPIRONOLACTONE 87 54 50 61
PROPRANOLOL HCL 86 63 52 115
AMLODIPINE BESYLATE-BENAZEPRIL 79 61 53 109
QUINAPRIL HCL 78 54 54 125
TIZANIDINE HCL 76 35 55 105
BUPROPION HCL SR 75 22 56 151
DIOVAN 73 46 57 58
FENTANYL 70 54 S2 58 60
PLAVIX 70 50 58 54
DONEPEZIL HCL 69 69 60 35
PREDNISONE 68 53 61 42
GLYBURIDE 67 60 R 62 69
FINASTERIDE 67 67 62 98
NEXIUM 66 45 64 28
COMBIVENT 65 41 65 78
PREMARIN 63 47 R 66 139
CARISOPRODOL 62 0 R 67 71
BYSTOLIC 58 46 68 108
PANTOPRAZOLE SODIUM 58 56 68 48
PAROXETINE HCL 57 54 70 59
AZITHROMYCIN 56 41 71 45
SULINDAC 55 50 72 256
SINGULAIR 54 15 73 67
CRESTOR 54 47 73 34
ENDOCET 52 28 S2 75 111
NAMENDA 51 51 76 47
ADVAIR DISKUS 50 37 77 37
TRIAMTERENE-HCTZ 50 26 77 62
ESTRADIOL 50 0 R 77 130
TERAZOSIN HCL 50 19 77 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.